找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Challenges and Solutions Against Visceral Leishmaniasis; Angamuthu Selvapandiyan,Ruchi Singh,Nirmal K. Gang Book 2023 The Editor(s) (if ap

[复制链接]
查看: 15815|回复: 59
发表于 2025-3-21 16:45:13 | 显示全部楼层 |阅读模式
书目名称Challenges and Solutions Against Visceral Leishmaniasis
编辑Angamuthu Selvapandiyan,Ruchi Singh,Nirmal K. Gang
视频videohttp://file.papertrans.cn/224/223425/223425.mp4
概述Discusses epidemiology, surveillance strategies, and control and management of Visceral Leishmaniasis.Reviews the applications of proteomic strategies for better diagnosis and vaccine development.Exam
图书封面Titlebook: Challenges and Solutions Against Visceral Leishmaniasis;  Angamuthu Selvapandiyan,Ruchi Singh,Nirmal K. Gang Book 2023 The Editor(s) (if ap
描述.This book comprehensively reviews the epidemiology and surveillance strategies of Visceral Leishmaniasis, and the latest developments in disease diagnosis, drug discovery, and vaccine development. The initial chapters cover the epidemiology features and spatial distribution of Visceral Leishmaniasis. The book further discusses the manifestations of HIV-Visceral Leishmaniasis infection on the immunopathogenesis, diagnosis, and therapeutic response. It analyzes the role of different proteomic technologies in understanding the parasite development, survival, drug resistance mechanisms, host-pathogen interactions, and the development of new therapeutic approaches. The book concludes by discussing recent advancements in vaccine development for Visceral Leishmaniasis. It discusses the promising vaccine candidate, their developmental status, current challenges, and prospects for rational vaccine development against Leishmania. This book is an invaluable source of information for students, and researchers working to understand the Leishmania biology, and drug development..
出版日期Book 2023
关键词Leishmania donovani; Visceral Leishmaniasis; Drug Discovery; Proteomics; Leishmania Vaccine
版次1
doihttps://doi.org/10.1007/978-981-99-6999-9
isbn_softcover978-981-99-7001-8
isbn_ebook978-981-99-6999-9
copyrightThe Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Singapor
The information of publication is updating

书目名称Challenges and Solutions Against Visceral Leishmaniasis影响因子(影响力)




书目名称Challenges and Solutions Against Visceral Leishmaniasis影响因子(影响力)学科排名




书目名称Challenges and Solutions Against Visceral Leishmaniasis网络公开度




书目名称Challenges and Solutions Against Visceral Leishmaniasis网络公开度学科排名




书目名称Challenges and Solutions Against Visceral Leishmaniasis被引频次




书目名称Challenges and Solutions Against Visceral Leishmaniasis被引频次学科排名




书目名称Challenges and Solutions Against Visceral Leishmaniasis年度引用




书目名称Challenges and Solutions Against Visceral Leishmaniasis年度引用学科排名




书目名称Challenges and Solutions Against Visceral Leishmaniasis读者反馈




书目名称Challenges and Solutions Against Visceral Leishmaniasis读者反馈学科排名




单选投票, 共有 1 人参与投票
 

0票 0.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

1票 100.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 22:26:29 | 显示全部楼层
Essentials in Leishmaniasis Elimination,there is no vaccine approved currently against any type of Leishmaniasis for use in humans. Recent studies have reported novel approaches to vaccine development and the important role of the innate immune system and its interaction with . for the development of an effective vaccine against leishmani
发表于 2025-3-22 04:12:20 | 显示全部楼层
Post Kala-Azar Dermal Leishmaniasis: Diagnosis and Treatment,or an accurate and rapid diagnosis of PKDL, loop-mediated isothermal amplification (LAMP) and recombinase polymerase amplification (RPA) have been used. Such assays can be used to assess the efficacy of new antileishmanial drugs and to assess the effectiveness of cures. The standard treatment for PK
发表于 2025-3-22 05:55:46 | 显示全部楼层
Emergence of Novel , Genetic Variants: A New Challenge to the Ongoing Leishmaniasis Elimination Pros forms are on an increase with reports of atypical CL caused by . genetic variants from the Indian subcontinent. The phenomenon points toward the possible emergence of novel parasite variants and calls for molecular surveillance of the heterogeneous parasite isolates from the known and newer endemi
发表于 2025-3-22 11:58:03 | 显示全部楼层
发表于 2025-3-22 16:51:03 | 显示全部楼层
发表于 2025-3-22 20:51:46 | 显示全部楼层
发表于 2025-3-22 22:42:36 | 显示全部楼层
发表于 2025-3-23 02:43:00 | 显示全部楼层
Miltefosine Unresponsiveness in Visceral Leishmaniasis,ally in endemic areas. Treatment outcome is governed by several factors related to host-parasite and drug kinetics. Host-related factors include host immunity or host nutritional status; for example, enhanced Th1-type response is crucial for effective treatment outcomes. Factors related to the drug,
发表于 2025-3-23 07:20:26 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 吾爱论文网 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
QQ|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-8-26 04:39
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表